Stocks / NASDAQ / Onconova Therapeutics, Inc.

Onconova Therapeutics, Inc.

Our Opinion

Onconova Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in discovery and development of some of their therapeutics.

Supporting Evidence:

The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.

“We have also conducted animal studies and clinical trials of recilisib under the FDA’s Animal Efficacy Rule, which permits marketing approval for new medical countermeasures for which conventional human efficacy studies are not feasible or ethical, by relying on evidence from studies in appropriate animal models to support efficacy in humans.” (Page 7) Read the full document

Company Description

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA. [Source: MarketWatch]

Company Website: